Detalles de la búsqueda
1.
A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients.
BMC Nephrol
; 16: 113, 2015 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26197758
2.
Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France.
BMC Gastroenterol
; 13: 39, 2013 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23448382
3.
Intradialytic hypotension and risk of cardiovascular disease.
Clin J Am Soc Nephrol
; 9(12): 2124-32, 2014 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25376764
4.
Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA.
Pragmat Obs Res
; 3: 57-67, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-27774018
5.
Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.
Clin Drug Investig
; 31(10): 703-15, 2011 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21756007
6.
On future non-medical costs in economic evaluations.
Health Econ
; 17(5): 579-91, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17787027
7.
Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study.
Value Health
; 5(2): 106-13, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11918826
Resultados
1 -
7
de 7
1
Próxima >
>>